Invention Grant
![8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions](/docs/US/2016-04-26/US09321791B2/abs.jpg.600x600.jpg)
- Patent Title: 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
-
Application No.: US14748792Application Date: 2015-06-24
-
Publication No.: US09321791B2Publication Date: 2016-04-26
- Inventor: Frank Himmelsbach , Elke Langkopf , Matthias Eckhardt , Michael Mark , Roland Maier , Ralf Lotz , Mohammad Tadayyon
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; David L. Kershner
- Priority: DE10238243 20020821; DE10312353 20030320
- Main IPC: C07D473/08
- IPC: C07D473/08 ; C07D519/00 ; C07D473/04 ; C07D473/06
![8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions](/abs-image/US/2016/04/26/US09321791B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
Public/Granted literature
Information query
